Fluorokinolon (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fluorokinolon" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

9doi.org

2^nd place

5^th place

4archive.org

6^th place

9^th place

2web.archive.org

1^st place

2^nd place

2nih.gov

4^th place

8^th place

1aafp.org

1,916^th place

382^nd place

1sfgate.com

166^th place

667^th place

1ajhp.org

low place

5,587^th place

1medscape.com

719^th place

152^nd place

aafp.org

Oliphant CM; Green GM (2002). »Quinolones: a comprehensive review«. Am Fam Physician. 65 (3): 455–64. PMID 11858629. Arhivirano iz prvotnega spletišča dne 29. septembra 2007. Pridobljeno 9. maja 2009.

ajhp.org

Fiscella RG; Lewis CC; Jensen MK (2007). »Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations«. Am J Health Syst Pharm. 64 (19): 2069–73. doi:10.2146/ajhp060667. PMID 17893419.

archive.org

Wolfson JS; Hooper DC (1989). »Fluoroquinolone antimicrobial agents«. Clin Microbiol Rev. 2: 378–424. doi:10.1128/CMR.2.4.378.
Lipsky BA; Baker CA (1999). »Fluoroquinolone toxicity profiles: a review focusing on newer agents«. Clin Infect Dis. 28 (2): 352–364. doi:10.1086/515104.
Kaatz, GW; Seo, SM; Ruble, CA (1993). »Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus«. Antimicrobial agents and chemotherapy. 37: 1086–1094. doi:10.1128/AAC.37.5.1086.
Brouillard, Jason E.; Terriff, Colleen M.; Tofan, Andrea; Garrison, Mark W. (2006). »Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents«. Pharmacotherapy. 26 (1): 3–14. doi:10.1592/phco.2006.26.1.3.

doi.org

Wolfson JS; Hooper DC (1989). »Fluoroquinolone antimicrobial agents«. Clin Microbiol Rev. 2: 378–424. doi:10.1128/CMR.2.4.378.
Fitton A. (1992). »The quinolones. An overview of their pharmacology«. Clin Pharmacokinet. 22 (1): 1–11. doi:10.2165/00003088-199200221-00003.
Lipsky BA; Baker CA (1999). »Fluoroquinolone toxicity profiles: a review focusing on newer agents«. Clin Infect Dis. 28 (2): 352–364. doi:10.1086/515104.
Gendrel D; Moulin F (2001). »Fluoroquinolones in paediatrics«. Paediatr. Drugs. 3 (5): 365–377. doi:10.2165/00128072-200103050-00005.
Just PM (1993). »Overview of the fluoroquinolone antibiotics«. Pharmacotherapy. 13: 4–17. doi:10.1002/j.1875-9114.1993.tb02710.x.
Hooper DC; Wolfson JS (1991). »Mode of action of the new quinolones: new data«. Eur J Clin Microbiol Infect Dis. 10 (4): 223–231. doi:10.1007/BF01966994.
Kaatz, GW; Seo, SM; Ruble, CA (1993). »Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus«. Antimicrobial agents and chemotherapy. 37: 1086–1094. doi:10.1128/AAC.37.5.1086.
Brouillard, Jason E.; Terriff, Colleen M.; Tofan, Andrea; Garrison, Mark W. (2006). »Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents«. Pharmacotherapy. 26 (1): 3–14. doi:10.1592/phco.2006.26.1.3.
Fiscella RG; Lewis CC; Jensen MK (2007). »Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations«. Am J Health Syst Pharm. 64 (19): 2069–73. doi:10.2146/ajhp060667. PMID 17893419.

medscape.com

»Classification Of Quinolones By Generation«.

nih.gov

pubmed.ncbi.nlm.nih.gov

Oliphant CM; Green GM (2002). »Quinolones: a comprehensive review«. Am Fam Physician. 65 (3): 455–64. PMID 11858629. Arhivirano iz prvotnega spletišča dne 29. septembra 2007. Pridobljeno 9. maja 2009.
Fiscella RG; Lewis CC; Jensen MK (2007). »Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations«. Am J Health Syst Pharm. 64 (19): 2069–73. doi:10.2146/ajhp060667. PMID 17893419.

sfgate.com

Schmid, Randolph E. (May 1, 2006). "Drug Company Taking Tequin Off Market". Associated Press. http://www.sfgate.com/cgi-bin/article.cgi?file=/news/archive/2006/05/01/national/w120748D88.DTL&type=health Arhivirano 2007-11-25 na Wayback Machine.. Retrieved on 2006-05-01.

web.archive.org

Oliphant CM; Green GM (2002). »Quinolones: a comprehensive review«. Am Fam Physician. 65 (3): 455–64. PMID 11858629. Arhivirano iz prvotnega spletišča dne 29. septembra 2007. Pridobljeno 9. maja 2009.
Schmid, Randolph E. (May 1, 2006). "Drug Company Taking Tequin Off Market". Associated Press. http://www.sfgate.com/cgi-bin/article.cgi?file=/news/archive/2006/05/01/national/w120748D88.DTL&type=health Arhivirano 2007-11-25 na Wayback Machine.. Retrieved on 2006-05-01.